Clinical Trials Browser

OTHER × Lymphoma, T-Cell, Peripheral × Prednisone × Clear all

NCT07535762 2026-04-17

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma

Phase 2 Not yet recruiting

Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

NCT06692452 2026-04-01

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

Phase 2 Withdrawn

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Enteropathy-Associated T-Cell Lymphoma

NCT06630091 2026-02-17

A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT02223208 2025-12-02

FIL_PTCL13

Phase 1/2 Active not recruiting

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Peripheral

NCT07258680 2025-12-02

BrEto-TCL

Phase 3 Enrolling by invitation

Lymphoma, T-Cell, Peripheral

NCT03719105 2025-08-08

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Peripheral, Leukemia, Large Granular Lymphocytic

NCT05958719 2024-12-30

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT01336933 2023-09-22

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

Phase 2 Completed

34 enrolled 12 charts

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

NCT04922567 2022-11-07

Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT05458180 2022-07-14

CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma

Phase 1 Unknown

Lymphoma, T-Cell, Peripheral

NCT05006664 2021-09-01

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT02445404 2020-10-22

Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT04061772 2019-08-20

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT03952572 2019-05-16

Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

Phase 3 Unknown

Lymphoma, T-Cell, Peripheral

NCT00136565 2018-08-23

Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

Phase 2 Completed

Lymphoma, T-Cell, Peripheral

NCT03553537 2018-06-12

Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Phase 3 Unknown

Lymphoma, T-Cell, Peripheral

NCT03321890 2017-10-26

Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Phase 2 Unknown

Recurrence, Lymphoma, T-Cell, Peripheral

NCT03023358 2017-01-18

Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients

Phase 3 Unknown

Lymphoma, T-Cell, Peripheral

NCT00337987 2015-02-27

A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma

Phase 2 Completed

49 enrolled 6 charts

Lymphoma, T-Cell, Peripheral

NCT00787527 2014-09-09

SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma

Phase 1/2 Completed

14 enrolled 8 charts

DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma